Navigation Links
Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Date:12/8/2011

ielding 43 million reads per each duplexed sample, 69 percent of which uniquely map to the human genome.  Standardized hazard ratios and p-values for the 21 Oncotype DX genes determined by RNA-Seq were comparable to those originally obtained using RT-PCR.  Additionally, whole transcriptome RNA-Seq revealed more than 1,800 new coding and non-coding RNAs associated with breast cancer recurrence risk, many of which belong to previously unrecognized gene networks. Additional research will be performed to determine whether these new genes can be observed in other cohorts and whether they add value beyond the 21 Oncotype DX genes.

The study, "Breast Cancer Recurrence Risk Probed by Whole Transcriptome Next-Generation Sequencing in 136 Patients," is presented on Thursday, December 8 at 7:00 a.m. CT.

About Genomic Health and the Oncotype DX® Tests
Genomic Health, Inc. (NASDAQ: GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions.

Its lead product, the Oncotype DX Breast Cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer to help optimize treatment options.  Oncotype DX is the only test incorporated in published ASCO® and NCCN® breast cancer treatment guidelines for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive.(1)  The test is also recognized in international guidelines issued by St. Gallen International Breast Cancer Expert Panel and European Society for Medical On
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 An experimental drug ... as a viable first treatment for anemia of inflammation, according ... the treatment published online today in Blood ... (ASH).    Anemia is a condition that ... do not function properly. When an individual has anemia, the ...
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com ... report is available in its catalogue: ... Application and Approval of Imported Medical ... (2014 Edition) ... Now, Chinese regulations on medical devices ...
(Date:8/27/2014)... BOSTON , Aug. 27, 2014  Columbia Laboratories, ... Company"), a provider of pharmaceutical development, clinical trial manufacturing, ... industry, today announced that it will participate at the ... Investment Conference, to be held in New ... conference at 11:15am on September 9, 2014 at the ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... Reinforces Anti-Inflammatory Properties of Red Hot ,Super,Fruit, ... study shows tart cherries,one of today,s hottest "Super ... of type 2 diabetes and cardiovascular disease,in animals. ... researchers,today at the Experimental Biology annual meeting. As ...
... 2008 Data from five studies sponsored,by Ortho ... National Kidney,Foundation (NKF) 2008 Spring Clinical Meetings from ... PROCRIT(R) (Epoetin alfa)., The data include studies ... (EPO) and darbepoetin alfa (DARB), evaluate medical costs,related ...
Cached Medicine Technology:Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease 2Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease 3Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 2Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 3Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 5Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 6
(Date:8/28/2014)... Bellevue, WA (PRWEB) August 28, 2014 ... a free downloadable ebook guide to the ... prepare themselves for surgery, the procedure itself, and how ... helpful tips and candid explanations. Dr. McIntosh also discusses ... how to help ensure that the procedure is as ...
(Date:8/28/2014)... San Diego, CA (PRWEB) August 28, 2014 ... age of 40 and are considered the leading cause of ... of the eye’s natural lens behind the iris, cataracts are ... year 2020, mostly due to an aging population. Cataracts are ... eye. Each year, Dr. Michael Tracy of Carlsbad Eye ...
(Date:8/28/2014)... NJ (PRWEB) August 28, 2014 Registration ... Run For The Warriors® in Holmdel, New Jersey on ... take place at the New Jersey Vietnam Veterans’ Memorial ... at the PNC Bank Arts Center. All proceeds of ... national nonprofit dedicated to restoring a sense of self, ...
(Date:8/28/2014)... York (PRWEB) August 28, 2014 An unprecedented ... and neck issues, Cloud 9 Spine offers their resources online ... problems can quickly become a brick wall of discouragement as ... a professional opinion, Cloud 9 Spine offers a ... technology merged with human interaction that sets Cloud 9 Spine ...
(Date:8/28/2014)... August 28, 2014 Alpine, NJ resident ... of his team, Zebras In Tiaras, to benefit the ... be held October 26, 2014 in Foley Square, New ... immunodeficiency community. Primary immunodeficiency diseases (PI) are a group ... which part of the body’s immune system is missing ...
Breaking Medicine News(10 mins):Health News:The Ultimate Guide to the Tummy Tuck Surgery eBook is Released by Dr. Bryan McIntosh 2Health News:Cataract Awareness Month an Opportunity to Focus on Vision Care and Ocular Health 2Health News:Hope For The Warriors Announces Second Annual NJ Run 2Health News:Making Waves on the East Coast, Cloud 9 Spine is Helping Patients Find Appointments With Local Spine Doctors 2
... financial results -, LAVAL, QC, Oct. 29 /PRNewswire-FirstCall/ ... it will host a conference call on,Friday, November 7 ... 2008,financial results. Labopharm will report its third quarter 2008 ... same day., To access the conference call by ...
... and KING OF PRUSSIA, Pa., Oct. 29 HighPoint,Solutions ... that as part of its growth strategy, it has ... new office. The new location will,be at 8750 W. ... office is conveniently located near O,Hare International,Airport., Glenn ...
... In Vitro Fertilization and ... Intrauterine Insemination Procedures, LA JOLLA, Calif., Oct. 29 ... it has entered into a,series of agreements to acquire exclusive ... to the use of,adenosine 5,-triphosphate (ATP) to improve motility of ...
... Sato Sports Plaza to investigate new muscle,training methods, ... to expand,global health and fitness research and partnerships, ... an international science and health,exchange to highlight scientific ... with Sato Sports Plaza of,Japan is the first ...
... PRGO ; TASE) today announced that it ... Drug Administration for its Abbreviated New,Drug Application (ANDA) ... mg. The national brand,s,exclusivity ends prior to the ... will be marketed under store brand labels and ...
... ARLINGTON, Va., Oct. 29 For Veterans Day,the ... a new 14-page,brochure on posttraumatic stress disorder (PTSD), ... line at http://www.nami.org/PTSD and is intended ... illness, along,with their families and caregivers., "PTSD ...
Cached Medicine News:Health News:Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET) 2Health News:HighPoint Solutions Expands with New Chicago Office 2Health News:Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program 2Health News:Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program 3Health News:New Program Internationalizes Health and Fitness Research 2Health News:Perrigo Announces FDA Tentative Approval for Ibuprofen PM 2Health News:Veterans Day: New PTSD Brochure - 'Transmission of Trauma' Can Span Generations 2
... The ACONO H. pylori Rapid Test Strip ... the qualitative detection of antibodies to Helicobacter ... or plasma to aid in the diagnosis ... years of age and older. They are ...
Clearview H. pylori II uses rapid, two-step technology for the direct detection of H. pylori antibodies. , ,The patented, innovative technology used by Clearview H. pylori II provides highly sen...
... read, qualitative immunochromatographic method for rapid detection ... that grows in the stomach and is ... gastric cancers. FlexSure HP, available for use ... provides the physician with the opportunity to ...
... The Acceava Mononucleosis test provides superior ... with a simple procedure that provides ... evaluations with competitive products will convince ... attributes enable you to deliver improved ...
Medicine Products: